Levocetirizine Dihydrochloride Solution
NDC Package 31722-659-31

11-digit billing NDC: 31722065931 · Billing unit: ML · 148 ML per package

Package Information

Levocetirizine Dihydrochloride solution is the use of levocetirizine dihydrochloride oral solution is contraindicated in:. This formulation utilizes a solution delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-659 and is authorized under FDA application ANDA210914.

Identification & Billing

NDC Package Code
31722-659-31
Package Description
1 BOTTLE in 1 CARTON / 148 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
31722065931
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
148 ML
RxNorm Crosswalk
  • RxCUI: 855168 - levocetirizine dihydrochloride 2.5 MG in 5 mL Oral Solution
  • RxCUI: 855168 - levocetirizine dihydrochloride 0.5 MG/ML Oral Solution
  • RxCUI: 855168 - levocetirizine dihydrochloride 2.5 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Levocetirizine Dihydrochloride
Non-Proprietary Name
Levocetirizine Dihydrochloride
Substance Name
Levocetirizine Dihydrochloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
The use of levocetirizine dihydrochloride oral solution is contraindicated in:

Regulatory & Marketing

Labeler Name
Camber Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA210914
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-01-2019
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 31722-659-31 identifies a specific commercial package of 1 bottle in 1 carton / 148 ml in 1 bottle of Levocetirizine Dihydrochloride, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This solution is formulated for oral use and contains levocetirizine dihydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on April 01, 2019. The current certification is valid through December 31, 2027.

How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722065931. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 148 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
31722-659-31
11-Digit CMS (5-4-2)
31722-0659-31

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.